Correlation Between Mereo BioPharma and OncoCyte Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and OncoCyte Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and OncoCyte Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and OncoCyte Corp, you can compare the effects of market volatilities on Mereo BioPharma and OncoCyte Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of OncoCyte Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and OncoCyte Corp.

Diversification Opportunities for Mereo BioPharma and OncoCyte Corp

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Mereo and OncoCyte is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and OncoCyte Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoCyte Corp and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with OncoCyte Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoCyte Corp has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and OncoCyte Corp go up and down completely randomly.

Pair Corralation between Mereo BioPharma and OncoCyte Corp

Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 1.12 times more return on investment than OncoCyte Corp. However, Mereo BioPharma is 1.12 times more volatile than OncoCyte Corp. It trades about 0.03 of its potential returns per unit of risk. OncoCyte Corp is currently generating about -0.01 per unit of risk. If you would invest  345.00  in Mereo BioPharma Group on September 1, 2024 and sell it today you would earn a total of  16.00  from holding Mereo BioPharma Group or generate 4.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Mereo BioPharma Group  vs.  OncoCyte Corp

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
OncoCyte Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Mereo BioPharma and OncoCyte Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and OncoCyte Corp

The main advantage of trading using opposite Mereo BioPharma and OncoCyte Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, OncoCyte Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoCyte Corp will offset losses from the drop in OncoCyte Corp's long position.
The idea behind Mereo BioPharma Group and OncoCyte Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies